About FDA Science

Science is the solid bedrock of all the FDA's decisions, whether they involve product review, research, policy development, or law enforcement. In recent years, findings by the FDA's scientists have been critical to the agency's most significant public health accomplishments.

The quickening pace of scientific discoveries is propelling the development of a tidal wave of novel, extremely complex products and processes that will soon put the FDA to a crucial test. They include genomics- and proteomics-assisted drug development and disease detection and diagnosis; robotics; nanotechnology; minimally invasive surgery and medical imaging; xenotransplantation and organ replacements; stem cell-derived products and assisted reproduction; biosensors and new drug delivery systems; individualized drug therapy; and transgenics.

As a global leader and the world's premier consumer protection regulatory agency, a strong FDA is essential to continued protection of the health of American consumers, and to improving public health worldwide.

The FDA is also about better dialogue with its many stakeholders and better communication of its science to that global audience.

FDA Science is an information and educational portal containing internet broadcasts of key FDA public meetings. The FDA is cooperating with Prous Science - a recognized leader in medical and scientific information and informatics - to present this new initiative to ensure a better and comprehensive dissemination of FDA's public meetings.

FDA Science is available without charge to a global audience.

Adapted in part from FDA Publication No. FS 01-13 (Revised: February 2002)

Webcast produced by Prous Science © Prous Science 2005. RealNetworks, RealPlayer and RealAudio are trademarks of RealNetworks, Inc.